← EverQuote, Inc.

Annual Trend FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Net income (loss) ($13.8m) ($7.1m) ($11.2m) ($19.4m) ($24.4m) ($51.3m) $32.2m $99.3m
Net Income From Continuing Operations — — — — ($24.4m) ($51.3m) $32.2m $99.3m
Depreciation and amortization expense $1.3m $2.2m $3.4m $5.1m $5.8m $6.2m $5.7m $3.8m
Depreciation Amortization Depletion — — — — $5.8m $6.2m $5.7m $3.8m
Depreciation And Amortization — — — — $5.8m $6.2m $5.7m $3.8m
Deferred taxes — — — ($2.5m) — — — ($38.4m)
Deferred Income Tax — — — — $0 $0 $0 ($38.4m)
Deferred Tax — — — — $0 $0 $0 ($38.4m)
Impairment of right-of-use asset — — — — — $384k — —
Asset Impairment Charge — — — — $0 $384k $0 $0
Operating lease right-of-use assets — — $2.1m $2.7m $2.6m $2.5m $2.2m $1.1m
Operating lease liabilities — — ($2.2m) ($2.8m) ($2.9m) ($3.0m) ($2.5m) ($1.1m)
Operating lease liabilities arising from obtaining right-of-use assets — — $541k $383k $1.1m $0 $4.0m $0
Stock-based compensation expense $7.1m $12.7m $24.2m $30.0m $29.0m $24.1m $20.6m $24.3m
Loss on sale of health assets — — — — — $19.4m — —
Change in fair value of contingent consideration liabilities — — $1.8m $196k ($4.1m) ($150k) — —
Provision for bad debt — $478k $105k ($41k) $693k $204k $13k $10k
Unrealized foreign currency transaction (gains) losses — — — $24k ($9k) $21k ($26k) $110k
Litigation accrual settled with sale of assets — — — — — — — $7.8m
Accounts receivable ($2.8m) ($15.2m) ($14.0m) $10.5m $5.4m $8.2m ($40.2m) ($13.8m)
Prepaid expenses and other current assets ($863k) ($5.6m) $623k ($3.6m) ($2.1m) $962k $440k ($4.4m)
Commissions receivable, current and non-current — — ($5.8m) ($16.9m) ($24.2m) $4.2m $4.9m $1.9m
Other assets — ($1k) ($554k) ($10.9m) ($19k) $421k ($291k) $137k
Accounts payable $4.9m $6.8m $9.3m ($4.0m) $1.1m ($13.4m) $42.7m $16.9m
Accrued expenses and other current liabilities $1.3m $10.1m ($4.0m) $2.7m ($2.4m) ($1.5m) $1.0m ($2.1m)
Deferred revenue $454k $61k $368k $227k ($229k) $5k ($107k) ($103k)
Acquisition of property and equipment, including costs capitalized for development of internal-use software ($3.7m) ($3.0m) ($3.8m) ($2.9m) ($4.3m) ($3.8m) ($4.1m) ($5.1m)
Proceeds from sale of health assets — — — — — $13.2m — —
Proceeds from exercise of stock options $861k $3.0m $4.9m $3.6m $942k $979k $3.6m $3.9m
Tax withholding payments related to net share settlement — — — — ($100k) ($402k) ($1.8m) ($4.0m)
Acquisition of property and equipment included in accounts payable $3.7m $3.0m $3.8m $100k $60k $25k $135k $125k
Assets sold in settlement of litigation accrual — — — — — — — $8.1m
Beginning Cash Position — — — — $35.1m $30.8m $38.0m $102.1m
Cash Flow From Continuing Financing Activities — — — — $15.8m $577k $1.7m ($21.1m)
Cash Flow From Continuing Investing Activities — — — — ($4.3m) $9.4m ($4.1m) ($5.1m)
Change In Account Payable — — — — $1.1m ($13.4m) $42.7m $16.9m
Change In Accrued Expense — — — — ($2.4m) ($1.5m) $1.0m ($2.1m)
Change In Other Current Assets — — — — $2.6m $2.9m $1.9m $1.3m
Change In Other Current Liabilities — — — — ($2.9m) ($3.0m) ($2.5m) ($1.1m)
Change In Other Working Capital — — — — ($229k) $5k ($107k) ($103k)
Change In Payable — — — — $1.1m ($13.4m) $42.7m $16.9m
Change In Payables And Accrued Expense — — — — ($1.3m) ($15.0m) $43.7m $14.8m
Change In Prepaid Assets — — — — ($2.1m) $962k $440k ($4.4m)
Change In Receivables — — — — ($18.9m) $12.4m ($35.3m) ($11.9m)
Change In Working Capital — — — — ($22.8m) ($1.7m) $8.1m ($1.6m)
Changes In Account Receivables — — — — $5.4m $8.2m ($40.2m) ($13.8m)
Changes In Cash — — — — ($4.2m) $7.1m $64.2m $69.3m
End Cash Position — — — — $30.8m $38.0m $102.1m $171.4m
Financing Cash Flow — — — — $15.8m $577k $1.7m ($21.1m)
Free Cash Flow — — — — ($20.1m) ($6.7m) $62.5m $90.3m
Investing Cash Flow — — — — ($4.3m) $9.4m ($4.1m) ($5.1m)
Issuance Of Capital Stock — — — $0 $15.0m $0 $0 —
Net Business Purchase And Sale — — — ($16.0m) $0 $0 — —
Net Foreign Currency Exchange Gain Loss — — — — ($9k) $21k ($26k) $110k
Net PPE Purchase And Sale — — — — ($4.3m) ($3.8m) ($4.1m) ($5.1m)
Operating Gains Losses — — — — ($9k) $19.4m ($26k) $110k
Other Non Cash Items — — — $196k ($4.1m) ($150k) — $7.8m
Proceeds From Stock Option Exercised — — — — $942k $979k $3.6m $3.9m
Provisionand Write Offof Assets — — — — $693k $204k $13k $10k
Purchase Of Business — — — ($16.0m) $0 $0 — —
Purchase Of PPE $3.7m $3.0m $3.8m $2.9m ($4.3m) ($3.8m) ($4.1m) ($5.1m)
Repurchase Of Capital Stock — — — — — $0 $0 ($21.0m)
Stock Based Compensation — — — — $29.0m $24.1m $20.6m $24.3m
Net cash provided by (used in) operating activities ($1.9m) $4.4m $10.7m $7.2m ($15.8m) ($2.8m) $66.6m $95.4m
Capital Expenditure — — — — ($4.3m) ($3.8m) ($4.1m) ($5.1m)
Net cash provided by (used in) investing activities ($3.7m) ($3.0m) ($18.8m) ($18.8m) ($4.3m) $9.4m ($4.1m) ($5.1m)
Proceeds from private placement of common stock — — — — $15.0m — — —
Issuance of Class A common stock — — — — $2.1m — — —
Common Stock Issuance — — — $0 $15.0m $0 $0 —
Net Common Stock Issuance — — — — $15.0m $0 $0 ($21.0m)
Repurchase of common stock — — — — — — — ($21.0m)
Common Stock Payments — — — — — $0 $0 ($21.0m)
Net Other Financing Charges — — — — ($100k) ($402k) ($1.8m) ($4.0m)
Net cash provided by (used in) financing activities $44.8m $3.0m $4.9m $3.6m $15.8m $577k $1.7m ($21.1m)
Effect of exchange rate changes on cash, cash equivalents and restricted cash — — ($7k) ($6k) ($27k) $18k $1k $3k
Effect Of Exchange Rate Changes — — — — ($27k) $18k $1k $3k
Net increase in cash, cash equivalents and restricted cash $39.3m $4.4m ($3.2m) ($8.0m) ($4.3m) $7.1m $64.2m $69.3m
Cash, cash equivalents and restricted cash at beginning of period $41.9m $46.3m $43.1m $35.1m $30.8m $38.0m $102.1m $171.4m
Change In Cash Supplemental As Reported — — — — ($4.3m) $7.1m $64.2m $69.3m
Income Tax Paid Supplemental Data — — — — $175k $589k $2.3m —

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.